Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-19.95%
↓ 181% vs avg
Percentile
P54
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-7.10%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -19.95% |
| Q3 2025 | 400.91% |
| Q2 2025 | 43.94% |
| Q1 2025 | -1174.18% |
| Q4 2024 | -91.41% |
| Q3 2024 | 171.56% |
| Q2 2024 | -131.23% |
| Q1 2024 | -207.56% |
| Q4 2023 | -68.70% |
| Q3 2023 | 158.91% |
| Q2 2023 | -94.73% |
| Q1 2023 | -144.48% |
| Q4 2022 | -301.18% |
| Q3 2022 | -11.32% |
| Q2 2022 | 135.93% |
| Q1 2022 | -195.52% |
| Q4 2021 | 329.95% |
| Q3 2021 | -60.69% |
| Q2 2021 | 169.49% |
| Q1 2021 | -233.21% |
| Q4 2020 | -61.78% |
| Q3 2020 | 65.36% |
| Q2 2020 | 950.62% |
| Q1 2020 | -97.48% |
| Q4 2019 | 32.54% |
| Q3 2019 | 120.26% |
| Q2 2019 | -41.21% |
| Q1 2019 | -24.55% |
| Q4 2018 | 2.26% |
| Q3 2018 | 158.16% |
| Q2 2018 | -47.07% |
| Q1 2018 | 56.40% |
| Q4 2017 | -52.61% |
| Q3 2017 | 136.06% |
| Q2 2017 | -70.77% |
| Q1 2017 | 210.61% |
| Q4 2016 | -48.24% |
| Q3 2016 | 291.07% |
| Q2 2016 | -455.63% |
| Q1 2016 | -84.38% |